Gemma L. Nixon - Concepedia

Author

Gemma L. Nixon

Also Known As

G. L. Nixon, G. Nixon, Gemma L Nixon, Gemma L. Nixon, Gemma Nixon, Gemma L. Nixon, Nixon, G., Nixon, G.L., Nixon, Gemma L.

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Liverpool Liverpool School of Tropical Medicine Imperial College London London School of Hygiene & Tropical Medicine GlaxoSmithKline (Spain)

About

Gemma L. Nixon is an author at University of Liverpool specializing in pharmacology, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	10	10	434
2	Medicine	9	9	416
3	Biochemistry	9	9	416
4	Chemical Biology	3	3	186
5	Engineering	1	1	18

Gemma L. Nixon

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Generation of quinolone antimalarials targeting the <i>Plasmodium falciparum</i> mitochondrial respiratory chain for the treatment and prophylaxis of malaria Giancarlo A. Biagini, Nicholas Fisher, Alison E. Shone, Proceedings of the National Academy of Sciences	2012	156
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides Rachel H. Clare, Catherine Bardelle, Paul Harper, Nature Communications	2018	128
Identification of a 1,2,4,5‐Tetraoxane Antimalarial Drug‐Development Candidate (RKA 182) with Superior Properties to the Semisynthetic Artemisinins Paul M. O’Neill, Richard K. Amewu, Gemma L. Nixon, Angewandte Chemie International Edition Antiparasitic AgentMalariaImmunologyPharmacotherapyPharmaceutical Chemistry	2010	123
Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting <i>Plasmodium falciparum</i> Type II NADH:Quinone Oxidoreductase (PfNDH2) Chandrakala Pidathala, Richard K. Amewu, Bénédicte Pacorel, Journal of Medicinal Chemistry Drug TargetPlasmodium FalciparumBiochemistryAntiparasitic AgentMedicine	2012	109
Targeting the Mitochondrial Electron Transport Chain of<i>Plasmodium Falciparum:</i>New Strategies Towards the Development of Improved Antimalarials for the Elimination Era Gemma L. Nixon, Chandrakala Pidathala, Alison E. Shone, Future Medicinal Chemistry	2013	66
AWZ1066S, a highly specific anti- <i>Wolbachia</i> drug candidate for a short-course treatment of filariasis W. David Hong, Farid Benayoud, Gemma L. Nixon, Proceedings of the National Academy of Sciences	2019	65
Synthesis, Antimalarial Activity, and Preclinical Pharmacology of a Novel Series of 4′-Fluoro and 4′-Chloro Analogues of Amodiaquine. Identification of a Suitable “Back-Up” Compound for <i>N-tert</i>-Butyl Isoquine Paul M. O’Neill, Alison E. Shone, Deborah Stanford, Journal of Medicinal Chemistry	2009	61
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance Paul M. O’Neill, Richard K. Amewu, Susan A. Charman, Nature Communications	2017	61
Identification, Design and Biological Evaluation of Heterocyclic Quinolones Targeting <i>Plasmodium falciparum</i> Type II NADH:Quinone Oxidoreductase (PfNDH2) Suet C. Leung, Peter Gibbons, Richard K. Amewu, Journal of Medicinal Chemistry Phosphate SaltMedicinal ChemistryBioorganic ChemistryPlasmodium FalciparumBiochemistry	2012	54
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of <i>Mycobacterium tuberculosis</i> W. David Hong, Peter Gibbons, Suet C. Leung, Journal of Medicinal Chemistry	2017	51

Page 1